Alternatives to BioNTech

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Advancing next-generation mRNA medicines.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

Developing novel therapeutics for challenging diseases using advanced biological insights.

Developing novel RNA-targeting compounds for cancer and rare genetic diseases.

Tech.Bio company advancing mRNA discovery with AI and its mRNA Lightning platform.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

Immunotherapy company targeting oncology and autoimmune diseases.

Clinical-stage immunotherapy company developing novel treatments for cancer.

South Korean biopharmaceutical company developing novel biologics for cancer and rare diseases.

Clinical-stage biopharmaceutical company developing novel boron-based small molecule therapeutics for rare infectious diseases and oncology.

Developing a next-generation, off-the-shelf, in vivo engineered monocyte immunotherapy platform for solid tumors.

A commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

Developing novel immunotherapies and diagnostics for cancer.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

Developing TCR-mimetic antibody therapies to treat cancer by targeting peptide-loaded major histocompatibility complexes.

Biotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.

AI-native biotech company designing next-generation CAR T therapies for solid tumors.

A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.

Developing Quantum ADCs against the tumor microenvironment for innovative cancer therapies.

A biotechnology company focused on oncology drug discovery.

Developing first-in-class oral therapy for BK polyomavirus infections.

Decoding the immune system to pioneer a paradigm shift in disease diagnosis and treatment.

Advancing targeted alpha therapies.

Developing a new histotripsy therapeutic platform for cancer treatment.

Biopharmaceutical company developing T-cell therapies for solid tumor cancers.

Developing precision medicines for inflammatory and immune-mediated diseases using AI and patient sample analysis.

Combines human immune organoid biology with generative AI to reduce immunogenicity risk in antibody development.

AI drug discovery startup that learns directly from patient biology to identify and design novel medicines, focusing on oncology and fibrosis.

Biotechnology company developing novel protein-based antimicrobial therapeutics.

Advancing biopsy specimen stewardship and expanding access to precision oncology.

Pioneering next-generation bispecific ADCs for cancer treatment.

Biotechnology company defining membrane protein spatial relationships to create novel therapeutics for cancer and autoimmune diseases.

Clinical-stage biopharmaceutical company developing next-generation antibody-drug conjugates (ADCs) for cancer treatment.

Developing novel immunotherapies for cancer.

Biotech startup developing an AI-powered drug platform targeting pancreatic cancer.

AI safety and research company building reliable, interpretable, and steerable AI systems.

Biotechnology company developing novel cancer fighting drugs that reprogram and redirect immune cells to fight cancer.

Clinical-stage biotech developing AI-driven metabolic immunotherapies for cancer and autoimmune diseases.

Biotechnology company developing and commercializing cell therapies for cancer treatment.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Global supplier of life science research tools, including antibodies, reagents, and assays.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

A vertically-integrated procurement platform for the life sciences industry.

Accelerating the world’s transition to a post-pathogen humanity.

Biopharmaceutical company developing mRNA-based vaccines and therapeutics for infectious diseases and cancer.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

A global leader in clinical pharmacology and bioanalytical sciences.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.